CYP4A22
Cytochrome P450 4A22
Also known as: CP4AM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TCH4
- Gene
- CYP4A22
- Ensembl
- ENSG00000162365
- Chromosome
- 1
- Canonical length
- 519 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 1p33. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
Canonical amino-acid sequenceUniProt
519 residues, UniProt reviewed canonical sequence.
>Q5TCH4|CYP4A22
1 MSVSVLSPSR RLGGVSGILQ VTSLLILLLL LIKAAQLYLH RQWLLKALQQ FPCPPSHWLF
61 GHIQEFQHDQ ELQRIQERVK TFPSACPYWI WGGKVRVQLY DPDYMKVILG RSDPKSHGSY
121 KFLAPRIGYG LLLLNGQTWF QHRRMLTPAF HNDILKPYVG LMADSVRVML DKWEELLGQD
181 SPLEVFQHVS LMTLDTIMKS AFSHQGSIQV DRNSQSYIQA ISDLNSLVFC CMRNAFHEND
241 TIYSLTSAGR WTHRACQLAH QHTDQVIQLR KAQLQKEGEL EKIKRKRHLD FLDILLLAKM
301 ENGSILSDKD LRAEVDTFMF EGHDTTASGI SWILYALATH PKHQERCREE IHGLLGDGAS
361 ITWNHLDQMP YTTMCIKEAL RLYPPVPGIG RELSTPVTFP DGRSLPKGIM VLLSIYGLHH
421 NPKVWPNLEV FDPSRFAPGS AQHSHAFLPF SGGSRNCIGK QFAMNQLKVA RALTLLRFEL
481 LPDPTRIPIP MARLVLKSKN GIHLRLRRLP NPCEDKDQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP4A22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 200 nTPM
Expression across tissuesHPA
Tissue
- liver: 200 nTPM
- kidney: 31 nTPM
- epididymis: 3.5 nTPM
- adipose tissue: 0.4 nTPM
- skin: 0.4 nTPM
- breast: 0.3 nTPM
Single-cell type
- hepatocytes: 150 nCPM
- proximal tubule cells: 23 nCPM
- epicardial cells: 4.5 nCPM
- epididymal principal cells: 1.1 nCPM
- podocytes: 1 nCPM
- fibro-adipogenic progenitors: 0.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 4.7 nTPM
- white matter: 3.8 nTPM
- amygdala: 3.6 nTPM
- basal ganglia: 3.2 nTPM
- hippocampal formation: 2.9 nTPM
- thalamus: 2.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.87
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.17
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate metabolic process
- icosanoid biosynthetic process
- kidney development
- lauric acid metabolic process
- linoleic acid metabolic process
- lipid hydroxylation
Molecular functions
- alkane 1-monooxygenase activity
- arachidonate monooxygenase activity
- heme binding
- iron ion binding
- long-chain fatty acid omega-hydroxylase activity
- 16-hydroxypalmitate dehydrogenase activity
- medium-chain fatty acid omega-hydroxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP4A22 as an antibody target. Whether an autoantibody or antibody against CYP4A22 could matter depends on whether native CYP4A22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP4A22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP4A22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...